Nanomedicine 2019-01
Exploring an interesting dual functionality of anacardic acid for efficient paclitaxel delivery in breast cancer therapy.
Only registered users can translate articles
Log In/Sign up
The link is saved to the clipboard
Keywords
Abstract
RESULTS
The nanoparticles (250-300 nm, 74% entrapment efficiency) showed approximately 2.26-fold higher apoptosis index and approximately 5.86-fold reduction in IC50 value compared with PTX in MCF-7 cells. Also, approximately 3.51- and 1.36-fold increase in area under the curve compared with Intaxel® and Nanoxel™ (both from Fresenius Kabi, Gurugram, India) was achieved. Significant tumor burden reduction (∼60%) and reduced toxicity was observed compared with marketed formulations.